SecBot SecBot
Home › SEC Filings › Insider Buy Activity

Insider Buy Activity

63 reports analyzed by SecBot AI · browse by date or by stock
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
TickerTypeSentimentImpactSummaryDate
ARTVINSIDER-BUYbullish7/10RA Capital Management, a director and 10% owner, purchased 1.43 million shares of Artiva Biotherapeutics for $11.14 millJun 16, 2026
PRTAINSIDER-BUYbullish5/1010% owner William P. Scully purchased $1.49M of Prothena stock in two open-market transactions from June 4-11, 2026, at Jun 12, 2026
AUPHINSIDER-BUYbullish6/10Aurinia CEO Kevin Tang made a conviction buy of ~552K shares (~$8.4M in open-market purchases) over three days, with bulJun 8, 2026
« Previous Page 3 of 3